Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
0.290
+0.040 (16.05%)
At close: Nov 20, 2024, 4:00 PM
0.268
-0.022 (-7.59%)
Pre-market: Nov 21, 2024, 8:03 AM EST
Aptevo Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 7.75 | 16.9 | 22.64 | 45.04 | 39.98 | 12.45 | Upgrade
|
| Cash & Short-Term Investments | 7.75 | 16.9 | 22.64 | 45.04 | 39.98 | 12.45 | Upgrade
|
| Cash Growth | -59.43% | -25.32% | -49.75% | 12.67% | 221.17% | -59.37% | Upgrade
|
| Accounts Receivable | - | - | 2.5 | 3.66 | 2.37 | - | Upgrade
|
| Receivables | - | - | 2.5 | 3.66 | 2.37 | - | Upgrade
|
| Prepaid Expenses | 1.64 | 1.47 | 1.57 | 1.82 | 2.23 | 1.08 | Upgrade
|
| Restricted Cash | - | - | - | 1.26 | 2.56 | - | Upgrade
|
| Other Current Assets | 0.62 | 0.69 | 0.74 | 0.78 | 0.13 | 16.47 | Upgrade
|
| Total Current Assets | 10.01 | 19.07 | 27.45 | 52.57 | 47.26 | 30 | Upgrade
|
| Property, Plant & Equipment | 5.13 | 5.78 | 6.77 | 3.96 | 5.54 | 7.69 | Upgrade
|
| Other Long-Term Assets | - | - | - | 0.07 | 0.75 | 15.72 | Upgrade
|
| Total Assets | 15.15 | 24.84 | 34.22 | 56.6 | 53.55 | 53.41 | Upgrade
|
| Accounts Payable | 3.53 | 3.98 | 3.5 | 3.46 | 5.58 | 6.43 | Upgrade
|
| Accrued Expenses | 0.92 | 2.1 | 2.11 | 2.08 | 2.76 | 2.87 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 2 | 11.67 | 5 | 19.86 | Upgrade
|
| Current Portion of Leases | - | 0.68 | 0.42 | - | - | - | Upgrade
|
| Current Unearned Revenue | - | - | - | 15.47 | - | - | Upgrade
|
| Other Current Liabilities | 1.43 | 0.46 | 0.68 | 2.09 | 1.2 | 9.08 | Upgrade
|
| Total Current Liabilities | 5.88 | 7.22 | 8.71 | 34.76 | 14.54 | 38.24 | Upgrade
|
| Long-Term Debt | - | - | 1.46 | 3.71 | 20.05 | - | Upgrade
|
| Long-Term Leases | 4.83 | 5.4 | 6.08 | 1.34 | 2.36 | 3.33 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | 15.58 | - | - | Upgrade
|
| Other Long-Term Liabilities | 0.01 | - | - | - | - | - | Upgrade
|
| Total Liabilities | 10.73 | 12.62 | 16.24 | 55.39 | 36.95 | 41.57 | Upgrade
|
| Common Stock | 0.08 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | Upgrade
|
| Additional Paid-In Capital | 245.6 | 235.61 | 223.96 | 215.23 | 202.15 | 179.65 | Upgrade
|
| Retained Earnings | -241.27 | -223.45 | -206.04 | -214.06 | -185.61 | -167.86 | Upgrade
|
| Shareholders' Equity | 4.42 | 12.22 | 17.97 | 1.22 | 16.59 | 11.84 | Upgrade
|
| Total Liabilities & Equity | 15.15 | 24.84 | 34.22 | 56.6 | 53.55 | 53.41 | Upgrade
|
| Total Debt | 4.83 | 6.08 | 9.96 | 16.72 | 27.41 | 23.19 | Upgrade
|
| Net Cash (Debt) | 2.92 | 10.83 | 12.68 | 28.33 | 12.57 | -10.74 | Upgrade
|
| Net Cash Growth | -78.40% | -14.62% | -55.24% | 125.46% | - | - | Upgrade
|
| Net Cash Per Share | 1.05 | 38.93 | 109.33 | 265.89 | 163.04 | -162.03 | Upgrade
|
| Filing Date Shares Outstanding | 18.51 | 0.53 | 0.16 | 0.11 | 0.1 | 0.07 | Upgrade
|
| Total Common Shares Outstanding | 17.05 | 0.44 | 0.15 | 0.11 | 0.1 | 0.07 | Upgrade
|
| Working Capital | 4.13 | 11.84 | 18.74 | 17.81 | 32.73 | -8.24 | Upgrade
|
| Book Value Per Share | 0.26 | 27.62 | 122.30 | 10.92 | 165.53 | 161.10 | Upgrade
|
| Tangible Book Value | 4.42 | 12.22 | 17.97 | 1.22 | 16.59 | 11.84 | Upgrade
|
| Tangible Book Value Per Share | 0.26 | 27.62 | 122.30 | 10.92 | 165.53 | 161.10 | Upgrade
|
| Machinery | - | 12.26 | 12.26 | 12.43 | 11.73 | 11.61 | Upgrade
|
| Leasehold Improvements | - | 2.23 | 2.23 | 2.23 | 2.23 | 2.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.